Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT04542616
NA
Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma
Sponsor: State University of New York at Buffalo
View on ClinicalTrials.gov
Summary
To compare the safety and efficacy of Baerveldt 350 and Ahmed ClearPath 250 tube shunts in lowering IOP in glaucoma patients.
Official title: Outcomes Comparison Between Baerveldt 350 and Ahmed ClearPath 250 Tube Shunts for the Treatment of Glaucoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2020-08-13
Completion Date
2024-07-31
Last Updated
2026-04-17
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation
Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation for the treatment of severe uncontrolled glaucoma.
Locations (1)
The Ira G. Ross Eye Institute
Buffalo, New York, United States